Non-Invasive Brain Stimulation in Corticobasal Syndrome

Non-Invasive Brain Stimulation in Corticobasal Syndrome

Overview

Non-invasive brain stimulation (NIBS) techniques, primarily [transcranial magnetic stimulation](/mechanisms/transcranial-magnetic-stimulation) (TMS) and [transcranial direct current stimulation](/mechanisms/transcranial-direct-current-stimulation) (tDCS), represent emerging therapeutic approaches for [corticobasal syndrome](/diseases/corticobasal-syndrome) (CBS). These techniques modulate cortical excitability and have shown promise in addressing both motor and cognitive symptoms in CBS and related tauopathies[@steven2020].

The rationale for NIBS in CBS stems from the condition's prominent cortical pathology, including motor cortex degeneration, intracortical inhibition deficits, and abnormal excitability patterns. Unlike pharmacological approaches that target neurotransmitter systems broadly, NIBS can selectively modulate specific cortical circuits affected in CBS, potentially addressing the underlying circuit dysfunction with greater precision[@benecke2001].

Transcranial Magnetic Stimulation (TMS)

Mechanisms of Action

TMS uses brief, high-intensity magnetic pulses to induce electrical currents in the cerebral cortex, stimulating neurons non-invasively through the intact skull.

Non-Invasive Brain Stimulation in Corticobasal Syndrome

Overview

Non-invasive brain stimulation (NIBS) techniques, primarily [transcranial magnetic stimulation](/mechanisms/transcranial-magnetic-stimulation) (TMS) and [transcranial direct current stimulation](/mechanisms/transcranial-direct-current-stimulation) (tDCS), represent emerging therapeutic approaches for [corticobasal syndrome](/diseases/corticobasal-syndrome) (CBS). These techniques modulate cortical excitability and have shown promise in addressing both motor and cognitive symptoms in CBS and related tauopathies[@steven2020].

The rationale for NIBS in CBS stems from the condition's prominent cortical pathology, including motor cortex degeneration, intracortical inhibition deficits, and abnormal excitability patterns. Unlike pharmacological approaches that target neurotransmitter systems broadly, NIBS can selectively modulate specific cortical circuits affected in CBS, potentially addressing the underlying circuit dysfunction with greater precision[@benecke2001].

Transcranial Magnetic Stimulation (TMS)

Mechanisms of Action

TMS uses brief, high-intensity magnetic pulses to induce electrical currents in the cerebral cortex, stimulating neurons non-invasively through the intact skull.

Key physiological effects in CBS:

• Induction of motor evoked potentials (MEPs): TMS over the motor cortex elicits contractions in target muscles via corticospinal pathways
• Modulation of intracortical inhibition: CBS patients show reduced short-interval intracortical inhibition (SICI) — repetitive TMS can normalize this
• Plasticity induction: High-frequency rTMS and theta-burst stimulation (TBS) promote long-term potentiation (LTP)-like changes
• Transcallosal effects: Stimulation of one hemisphere can modulate contralateral motor cortex via corpus callosum pathways[@marchesini2023]

Repetitive TMS (rTMS) Protocols

High-frequency rTMS (>5 Hz):

• Increases cortical excitability
• Applied to primary motor cortex (M1) for motor symptoms
• Typical parameters: 10 Hz, 20 sessions, 90-120% motor threshold

• Decreases cortical excitability
• Used for suppressing hyperactive regions
• May address cortical hyperexcitability in CBS[@lepieb2022]

• Intermittent TBS (iTBS): 600 pulses over 192 seconds, promotes excitability
• Continuous TBS (cTBS): 600 pulses, reduces excitability
• Emerging protocol with potentially faster effects

• MRI-guided targeting for precise stimulation of specific cortical areas
• Improves accuracy and reduces variability in outcomes

Clinical Applications in CBS

Motor Symptoms

Dystonia and Rigidity:

• High-frequency rTMS over the primary motor cortex contralateral to affected limb
• Studies report 30-50% improvement in dystonia severity scales[@lepieb2022]
• Combined with physical therapy may enhance motor gains

• Low-frequency rTMS over supplementary motor area (SMA) or parietal cortex
• Cortical myoclonus in CBS may respond to inhibitory stimulation
• Mixed results; some patients show reduction in myoclonic jerks

• High-frequency rTMS over motor cortex or cerebellum
• Limited evidence; motor improvement is modest
• May be combined with medication for enhanced effect

Cognitive and Behavioral Symptoms

Executive dysfunction:

• rTMS over [dorsolateral prefrontal cortex](/brain-regions/dorsolateral-prefrontal-cortex) (DLPFC)
• May improve task-switching, working memory, and inhibition[@chen2021]
• Limited by progressive cognitive decline in CBS

• rTMS over premotor cortex or inferior parietal lobule
• Theoretical benefit for motor planning deficits
• Experimental; no large controlled trials

• rTMS over left inferior frontal gyrus (Broca's area) for aphasia
• May support speech therapy gains
• Evidence limited to small case series

Neurophysiological Monitoring

Motor threshold assessment:

• Resting motor threshold (RMT) — indicator of corticospinal excitability
• CBS patients often show elevated RMT reflecting neurodegeneration

• Short-interval intracortical inhibition (SICI) is reduced in CBS
• rTMS can normalize some of these abnormalities[@marchesini2023]

• Used to assess and enhance sensorimotor plasticity
• May predict response to rTMS treatment

Transcranial Direct Current Stimulation (tDCS)

Mechanisms of Action

tDCS applies low-intensity direct current (1-2 mA) via scalp electrodes to modulate cortical excitability.

Key effects:

• Anodal stimulation: Increases cortical excitability, promotes depolarization
• Cathodal stimulation: Decreases excitability, promotes hyperpolarization
• Neuroplasticity: Modulates NMDA receptor activity, promotes synaptic strengthening
• Regional targeting: Can focus on specific cortical regions affected in CBS[@chen2021]

tDCS Protocols for CBS

Motor Cortex Stimulation

Primary motor cortex (M1) anodal tDCS:

• Electrode placement over C3/C4 (international 10-20 system)
• Current: 1-2 mA, 20-30 minutes per session
• Duration: 5-10 sessions over 2-4 weeks
• May improve motor function in CBS with combined rehabilitation

• Targeting [cerebellum](/cell-types/cerebellar-purkinje-motor-coordination) for gait and postural symptoms
• Cathodal over cerebellum may reduce abnormal cerebello-thalamic output
• Emerging evidence in other parkinsonian syndromes

Prefrontal Cortex Stimulation

DLPFC tDCS for cognitive symptoms:

• Left DLPFC anodal stimulation for executive dysfunction[@chen2021]
• Bilateral tDCS for more widespread cognitive involvement
• May improve working memory, attention, and task completion

• Medial prefrontal cortex stimulation may address motivational deficits

Combination Approaches

Motor + cognitive dual-target:

• M1 + DLPFC simultaneous or sequential stimulation
• Sequential protocol: morning motor session, afternoon cognitive session
• May address both motor and cognitive symptom domains

Clinical Evidence in CBS

• Limited controlled trials specifically in CBS
• Evidence extrapolated from PD, PSP, and FTD studies
• Small case series and open-label studies suggest modest benefit
• tDCS is generally well-tolerated with minimal side effects

Comparative Analysis

| Parameter | rTMS | tDCS |
|-----------|------|------|
| Mechanism | Magnetic induction of current | Direct electrical modulation |
| Depth of penetration | Deep (3-4 cm) | Superficial (1-2 cm) |
| Focality | High (with neuronavigation) | Moderate (large electrodes) |
| Session duration | 20-45 min | 20-30 min |
| Number of sessions | 5-20 | 10-20 |
| Pain/discomfort | Mild (scalp discomfort) | Minimal (tingling) |
| Motor effect size | Moderate | Small-Moderate |
| Cognitive effect size | Small-Moderate | Small |
| Availability | Specialized centers | More widely available |
| Cost | Higher | Lower |

Safety Considerations

TMS Safety

• Contraindications: Metallic implants, pacemakers, epilepsy (relative)
• Side effects: Scalp discomfort, headache, transient hearing changes
• Seizure risk: Very low with standard protocols (<0.1%)
• Cognitive effects: Generally minimal; some reports of transient confusion

tDCS Safety

• Skin irritation: Mild erythema under electrodes (common)
• Headache: Usually transient
• Cognitive effects: No significant adverse cognitive changes reported
• Long-term safety: Considered excellent for repeated use

Special Considerations for CBS Patients

• Cognitive impairment may limit ability to cooperate with procedures
• Asymmetric presentation requires careful lateralization of stimulation targets
• Disease progression may necessitate adjustment of stimulation parameters
• Careful assessment of benefit vs burden for each patient

Integration with Standard Care

Combined with Rehabilitation

Motor rehabilitation:

• rTMS or tDCS combined with [physical therapy](/diseases/physical-occupational-therapy-corticobasal-syndrome) for enhanced motor recovery
• Timing: stimulation before or during rehabilitation may prime cortical circuits

• tDCS over motor cortex during task practice
• May enhance motor learning and functional improvement

• tDCS over left inferior frontal gyrus during speech practice
• May augment aphasia therapy gains

Timing and Scheduling

• Acute effects during/after stimulation sessions
• Cumulative effects across multiple sessions (typically 2-4 weeks)
• Maintenance sessions may be required (weekly or biweekly) for sustained benefit
• Integration with [botulinum toxin](/diseases/botulinum-toxin-therapy-cbs) treatment cycles

Emerging Approaches

Theta-Burst Stimulation (TBS)

• Faster protocol with comparable effects to standard rTMS
• Intermittent TBS (iTBS) for excitatory effects
• May reduce treatment burden with fewer sessions needed

Spinal Cord Stimulation

• Not strictly non-invasive but less invasive than DBS
• Under investigation for motor symptoms in CBS and PSP

Combination Protocols

• rTMS + tDCS combined targeting
• Dual-site stimulation (e.g., motor cortex + cerebellum)
• Personalized targeting based on individual symptom profiles

Key References